Correlation Between Acrivon Therapeutics, and Rallybio Corp
Can any of the company-specific risk be diversified away by investing in both Acrivon Therapeutics, and Rallybio Corp at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Acrivon Therapeutics, and Rallybio Corp into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Acrivon Therapeutics, Common and Rallybio Corp, you can compare the effects of market volatilities on Acrivon Therapeutics, and Rallybio Corp and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Acrivon Therapeutics, with a short position of Rallybio Corp. Check out your portfolio center. Please also check ongoing floating volatility patterns of Acrivon Therapeutics, and Rallybio Corp.
Diversification Opportunities for Acrivon Therapeutics, and Rallybio Corp
0.37 | Correlation Coefficient |
Weak diversification
The 3 months correlation between Acrivon and Rallybio is 0.37. Overlapping area represents the amount of risk that can be diversified away by holding Acrivon Therapeutics, Common and Rallybio Corp in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Rallybio Corp and Acrivon Therapeutics, is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Acrivon Therapeutics, Common are associated (or correlated) with Rallybio Corp. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Rallybio Corp has no effect on the direction of Acrivon Therapeutics, i.e., Acrivon Therapeutics, and Rallybio Corp go up and down completely randomly.
Pair Corralation between Acrivon Therapeutics, and Rallybio Corp
Given the investment horizon of 90 days Acrivon Therapeutics, Common is expected to under-perform the Rallybio Corp. In addition to that, Acrivon Therapeutics, is 1.64 times more volatile than Rallybio Corp. It trades about -0.11 of its total potential returns per unit of risk. Rallybio Corp is currently generating about 0.03 per unit of volatility. If you would invest 104.00 in Rallybio Corp on August 28, 2024 and sell it today you would earn a total of 1.00 from holding Rallybio Corp or generate 0.96% return on investment over 90 days.
| Time Period | 3 Months [change] |
| Direction | Moves Together |
| Strength | Very Weak |
| Accuracy | 100.0% |
| Values | Daily Returns |
Acrivon Therapeutics, Common vs. Rallybio Corp
Performance |
| Timeline |
| Acrivon Therapeutics, |
| Rallybio Corp |
Acrivon Therapeutics, and Rallybio Corp Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Acrivon Therapeutics, and Rallybio Corp
The main advantage of trading using opposite Acrivon Therapeutics, and Rallybio Corp positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Acrivon Therapeutics, position performs unexpectedly, Rallybio Corp can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Rallybio Corp will offset losses from the drop in Rallybio Corp's long position.| Acrivon Therapeutics, vs. Eliem Therapeutics | Acrivon Therapeutics, vs. HCW Biologics | Acrivon Therapeutics, vs. Scpharmaceuticals | Acrivon Therapeutics, vs. Milestone Pharmaceuticals |
| Rallybio Corp vs. Century Therapeutics | Rallybio Corp vs. Edgewise Therapeutics | Rallybio Corp vs. C4 Therapeutics | Rallybio Corp vs. Mineralys Therapeutics, Common |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Analyst Advice module to analyst recommendations and target price estimates broken down by several categories.
Other Complementary Tools
| Equity Search Search for actively traded equities including funds and ETFs from over 30 global markets | |
| Competition Analyzer Analyze and compare many basic indicators for a group of related or unrelated entities | |
| Balance Of Power Check stock momentum by analyzing Balance Of Power indicator and other technical ratios | |
| Idea Optimizer Use advanced portfolio builder with pre-computed micro ideas to build optimal portfolio | |
| Alpha Finder Use alpha and beta coefficients to find investment opportunities after accounting for the risk |